image
Healthcare - Biotechnology - NASDAQ - US
$ 61.53
0.457 %
$ 11.7 B
Market Cap
37.07
P/E
Price Target Average
58.69%
Revenue Forecast Estimate
16.63%
EBIT Estimate
--51.08%
Net Income Estimate
89.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets BioMarin Pharmaceutical Inc.
image
Wall Street analysts predict an average 1-year price target for BMRN of $97.6 , with forecasts ranging from a low of $65 to a high of $122 .
BMRN Lowest Price Target Wall Street Target
65 USD 5.64%
BMRN Average Price Target Wall Street Target
97.6 USD 58.69%
BMRN Highest Price Target Wall Street Target
122 USD 98.28%
REVENUE FORECAST

Revenue Forecast Chart BMRN

image
EBIT FORECAST

EBIT Forecast Chart BMRN

image
NET INCOME FORECAST

Net Income Chart BMRN

image